Proteins of Streptococcus mutans MT703 were isolated by differential filtration from chemically defined culture medium following growth of the bacteria. Incubation of this preparation with cryostat-cut sections of fresh rabbit cardiac muscle resulted in deposition of streptococcal components on basement membranes of sarcolemmal sheaths and capillary walls, as indicated by indirect immunofluorescence assay. Binding of radioiodinated streptococcal proteins to heart in vitro was time dependent and saturable. Unlabeled S. mutans proteins competitively inhibited 72% of heart binding by the radiolabeled proteins, indicating a high level of binding specificity. A selection of components common to tissue basement membranes was tested for their abilities to inhibit the binding of streptococcal proteins to heart tissue. Of the glycosaminoglycans, heparin was the most effective inhibitor, followed by heparan sulfate and chondroitin sulfate. Hyaluronic acid was not inhibitory. Of the glycoproteins tested, laminin and collagen type IV were weakly inhibitory, whereas fibronectin was ineffective. A single polypeptide was purified to homogeneity by affinity chromatography on a column of heparin-agarose. Gel filtration chromatography of the purified protein under nondissociating conditions showed a single component at 31 kilodaltons (kDa), whereas in sodium dodecyl sulfate-polyacrylamide gel electrophoresis one band appeared at 8 kDa. This indicates that the tissue-binding protein may either be a linear polypeptide or be released into the environment by the bacterium as a tetramer of the 8-kDa polypeptide. The purified protein had an isoelectric point of 9.5 and showed binding activity for basement membranes in thin sections of heart. Chemical analyses of the purified binding protein showed it to have high contents of lysine and alanine and to be devoid of half-cystine, methionine, tyrosine, histidine, and both neutral and amino sugars.
Proteins of Streptococcus mutans MT703 were isolated by differential filtration from chemically defined culture medium following growth of the bacteria. Incubation of this preparation with cryostat-cut sections of fresh rabbit cardiac muscle resulted in deposition of streptococcal components on basement membranes of sarcolemmal sheaths and capillary walls, as indicated by indirect immunofluorescence assay. Binding of radioiodinated streptococcal proteins to heart in vitro was time dependent and saturable. Unlabeled S. mutans proteins competitively inhibited 72% of heart binding by the radiolabeled proteins, indicating a high level of binding specificity. A selection of components common to tissue basement membranes was tested for their abilities to inhibit the binding of streptococcal proteins to heart tissue. Of the glycosaminoglycans, heparin was the most effective inhibitor, followed by heparan sulfate and chondroitin sulfate. Hyaluronic acid was not inhibitory. Of the glycoproteins tested, laminin and collagen type IV were weakly inhibitory, whereas fibronectin was ineffective. A single polypeptide was purified to homogeneity by affinity chromatography on a column of heparin-agarose. Gel filtration chromatography of the purified protein under nondissociating conditions showed a single component at 31 kilodaltons (kDa), whereas in sodium dodecyl sulfate-polyacrylamide gel electrophoresis one band appeared at 8 kDa. This indicates that the tissue-binding protein may either be a linear polypeptide or be released into the environment by the bacterium as a tetramer of the 8-kDa polypeptide. The purified protein had an isoelectric point of 9.5 and showed binding activity for basement membranes in thin sections of heart. Chemical analyses of the purified binding protein showed it to have high contents of lysine and alanine and to be devoid of half-cystine, methionine, tyrosine, histidine, and both neutral and amino sugars.
Streptococcus mutans is commonly found in supragingival dental plaque and is considered to be the major etiologic agent of pit and fissure caries in humans (5, 12, 13) . In addition, it can enter the bloodstream as a consequence of trauma to oral mucosa and colonize heart valves and the endocardium, resulting in a subacute bacterial endocarditis (7, 16) .
Immunization of rabbits with suspensions of disrupted S. mutans cells results in the production of serum antibodies that bind in vitro to human, rabbit, and monkey cardiac muscle (9, 19, 23) . It was recently determined that these antibodies have specificities identical to those of autoantibodies found at low concentration in the sera of nonimmunized rabbits and are not cross-reactive with S. mutans. Thus, it is likely that increased production of heart-reactive antibodies during immunization resulted from injury of muscle fibers by streptococcal components that exposed hidden self-antigens and stimulated preexisting clones of self-reactive B lymphocytes (20, 21) . The contribution of these autoantibodies to the pathogenesis of heart disease has not been determined; however, myocardial lesions have been observed in rabbits that were injected with S. mutans components (9, 20) . These lesions appeared as perivascular infiltrations of polymorphonuclear cells and plasma cells. Immunofluorescence staining revealed granular deposits of immunoglobulins along sarcolemmal sheaths and capillaries; however, it was not clear whether the antibodies were bound directly to heart components or to streptococcal antigens previously deposited in the heart. Intravenous injection of disrupted S. mutans into rabbits also results in a severe nephritis, involving glomeruli, tubules, and interstitium (1, 19) . The histopathologic and immunopathologic features of the disease resemble those of streptococcus-associated nephritides in humans, particularly the diffuse glomerular nephritis often associated with subacute bacterial endocarditis (1, 6) . Immunofluorescence assays of monkey and rabbit tissues treated in vitro with extracts of S. mutans showed that this opportunistic pathogen contains proteins that bind directly to basement membranes of capillary walls and sarcolemmal sheaths of cardiac muscle and to basement membranes of renal tubules and glomeruli (18, 19) .
The present study was undertaken to identify and characterize components of S. mutans that may contribute to its pathogenicity in heart disease. In this report, we describe the purification and properties of a protein that has binding activity for glycosaminoglycans and basement membranecontaining structures of cardiac muscle.
MATERIALS AND METHODS Bacteria and culture conditions. S. mutans MT703 (serotype e) was grown in chemically defined medium (22) Binding assay. Heart-binding activity of streptococcal proteins was determined by using a radioisotope assay. A suspension of homogenized tissue (50,g of protein in 0.1 ml) was dispensed into wells of a 96-well vinyl assay plate (Costar, Cambridge, Mass.) and incubated at 4°C overnight. Tissue-coated wells and control wells without tissue were pretreated subsequently with 0.2 ml of PBS containing 1% bovine serum albumin for 1 h and 0.2 ml of PBS-0.05% Triton X-100 (PBS-Triton) for 20 min. The wells were then incubated with 0.1mlof 125I-labeled streptococcal proteins in PBS-Triton for 1 h and rinsed three times with PBS-Triton to remove unbound reactants, and the radioactivity was counted on a gamma radiation counter.
When selected substances were tested as inhibitors of the binding of radiolabeled streptococcal proteins to heart tissue, inhibitors were added to radiolabeled extracellular proteins (50 jig/ml) and assayed as described above after 1 h at room temperature.
Enzyme-linked immunosorbent assay (ELISA) was also used to determine binding to tissue by unlabeled bacterial components. The tissue-coated wells were incubated sequentially with 0.1 ml of bacterial components, goat anti-S. mutans serum (1:200) , and rabbit anti-goat immunoglobulin G (IgG) conjugated to alkaline phosphatase (1:1,000). Each step was followed by two washes with PBS-Triton. The wells were incubated with 0.1 ml of p-nitrophenylphosphate (1 mg/ml) in 9.7% (vol/vol) diethylamine buffer, pH 9.8, for 20 min. The reaction was stopped by adding 0.05 ml of 1.5 M NaOH, and the A405 was determined with an ELISA reader (model EL310; BIO-TEK Instruments Inc., Burlington, Vt.). The wells without tissue were used as a control. Absorbance of the streptococcal antigen-treated tissue was corrected against absorbance of the control.
Affinity chromatography. Streptococcal components (2.5 g [dry weight]) were dissolved in 250 ml of PBS. The solution was adjusted to pH 7.3 and centrifuged at 12,000 x g at 40C for 1 h. The supernatant was loaded on a column (1 by 17.5 cm) of heparin-agarose (Sigma Chemical Co., St. Louis, Mo.). The column was washed extensively with 0.01 M sodium phosphate, pH 7.3, containing 0.5 M NaCl. A continuous salt gradient from 0.5 to 1.2 M NaCl was used to elute the bound proteins. After dialysis and lyophilization, the column peaks were dissolved in 10 ml of PBS and rechromatographed on the heparin-agarose column. The eluted fractions were dialyzed and lyophilized.
Gel filtration chromatography. Molecular weights of proteins under nondissociating conditions were determined by using a column (1 by 30 cm) of Superose 6 (Pharmacia, Uppsala, Sweden) equilibrated with 10 mM phosphate, pH 7.2, containing 0.5 M NaCl, at a flow rate of 0.4 ml/min. The chromatography system included a high-performance liquid chromatography system (model 342; Beckman Instruments, Inc., Berkeley, Calif.) and a model HM/HPLC Holochrome detector (Gilson, Middletown, Wis.). The void volume and total volume of the column were determined by using blue dextran and acetone, respectively. Ferritin (440 kilodaltons [kDa] ), aldolase (158 kDa), ovalbumin (45 kDa), chymotrypsin (25 kDa), and aprotinin (6.5 kDa), were used as molecular weight standards.
Antibody purification. IgG was fractionated by adding ammonium sulfate to goat anti-S. mutans serum (33% saturation). The resulting IgG was loaded on a column of CNBr-activated Sepharose 4B (Pharmacia), cross-linked to streptococcal protein (0.9 mg/ml), by the procedure specified by the manufacturer. After the column was washed with PBS containing 0.5 M NaCl, the specific antibodies were eluted with 3 M KSCN in 0.5 M NH40H. The antibodies were dialyzed against PBS before use.
Immunofluorescence assay. Cryostat-cut sections (3,um thick) of fresh cardiac muscle from New Zealand White Rabbits were incubated with streptococcal components for 1 h, followed by 15 min of washing with PBS. The tissue was then incubated with diluted goat anti-S. mutans serum or affinity-purified antibodies for 1 h, followed by a 15-min wash in PBS. The tissue was then incubated for 1 h with fluorescein isothiocyanate-conjugated affinity-purified rabbit anti-goat IgG (1:20) (Organon Teknika, West Chester, Pa.), followed by a 15-min washing in PBS. For controls, tissue not pretreated with bacterial components was incubated with the same serological reagents.
Electrophoresis. Discontinuous sodium dodecyl sulfatepolyacrylamide gel electrophoresis was performed with 13.5% acrylamide gels by the method of Laemmli (11) . Lysozyme (14.3 kDa), lactoglobulin (18.4 kDa), carbonic anhydrase (29 kDa), ovalbumin (45 kDa), and bovine serum albumin (67 kDa) were used as molecular weight standards. Horse heart myoglobin (17 kDa) and its cleaved polypeptides (14.4, 8.2, 6 .2, and 2.5 kDa) (Sigma) were also used as molecular weight standards. Gels were silver stained by the procedure of Morrisey (14) .
The isoelectric point of the protein was determined with a 5% polyacrylamide gel containing 2% Ampholine 3.5-10 (LKB-Pharmacia, Bromma, Sweden) by the procedure provided by the manufacturer. purified to apparent homogeneity by a second passage through the heparin-agarose column (Fig. 5) . When the affinity-purified protein was examined by gel filtration chromatography on a Superose 6 column under nondissociating conditions, a single component was eluted with an apparent molecular mass of 31 kDa (Fig. 6 ). This indicates that the heparin-binding protein of S. mutans is either a tetramer of the 8-kDa polypeptide or a linear polypeptide with nominal tertiary structure. Monospecific antibodies prepared to the 8-kDa polypeptide did not react with larger S. mutans components in Western immunoblot assays. This observation together with the precise and reproducible molecular mass value make it unlikely that the 8-kDa protein is a product of random proteolysis in the culture fluid. The purity of the binding protein was confirmed by detection of only one component in Western blot assays with rabbit anti-S. mutans sera and in isoelectric focusing experiments. The yield of the purified protein was 9.1 mg from 4.3 g of streptococcal protein derived from 60 liters of culture medium. Characterization. The heart-binding activity of the proteins in the column fractions was determined by ELISA (Fig.  7) , using goat anti-S. mutans serum and alkaline phosphatase-conjugated anti-goat IgG antibody. Peak B material and the purified 8-kDa protein bound strongly to heart, whereas peak A showed little binding activity. To determine the structures of cardiac muscle that bind this streptococcal component; cryostat-cut sections of fresh rabbit heart were treated with the unfractionated streptococcal proteins or the 8-kDa protein and stained by indirect immunofluorescence, using affinity-purified goat antibodies to the 8-kDa protein as the primary serological reagent ( 8). Microscopic examination revealed that with both preparations, the streptococcal component bound linearly and homogeneously to sarcolemmal sheaths and perivascular areas of the muscle tissue. The staining patterns were similar to those obtained when antisera to whole S. mutans was used in the assay (18) .
Isoelectric focusing revealed that the purified binding protein was a single polypeptide with an isoelectric point of 9.5. Amino acid analysis showed that the protein contained large amounts of lysine and alanine. Half-cystine, methionine, tyrosine, and histidine were absent (Table 2) . Neither neutral nor amino sugars were detected in the purified protein.
DISCUSSION
Binding of radioiodinated components of S. mutans MT703 to rabbit cardiac muscle showed saturation kinetics, time dependence, and sensitivity to competitive inhibition by unlabeled streptococcal and tissue components. These pharmacologic criteria indicate that binding of radiolabeled proteins (72%) to heart involved stereochemical specificity rather than nonspecific adsorption (8) . Preformed complexes of heart and streptococcal components were only partially (<40%) dissociated by incubation with unlabeled streptococcal components over 24 h. This unexpectedly low value indicates that binding to cardiac muscle components may lead to conformational changes in the streptococcal protein that make competitive dissociation of complexes by free proteins difficult.
Except for hyaluronic acid, glycosaminoglycans inhibited binding of proteins of S. mutans to heart tissue. Inhibitory activity may be correlated with the density of anionic substituents of the molecule. The glycosaminoglycans are acidic polysaccharides containing both uronic acids and amino sugars. In addition, most glycosaminoglycans contain 0-and N-linked sulfate groups (24) . Heparin, a serum component, averages three sulfate groups per repeating dissacharide unit, whereas heparan sulfate, a structural analog present in tissue, contains only one. Hyaluronic acid is not sulfated. Successful dissociation of the binding protein from heparin-agarose by 1 M NaCl suggested that the binding is mediated largely by ionic interactions between oppositely charged polymers. This conclusion is substantiated by the properties of the purified streptococcal protein.
FIG. 8 Immunofluorescence staining of rabbit heart tissue pretreated with unfractionated streptococcal components (2 mg/ml) (A), purified 8-kDa protein (20 p.g/ml) (B), and PBS without streptococcal components (C). Magnification, x400.
Its isoelectric point of 9.5 and high content of lysine indicate that the binding protein has a net positive charge at physiological pH due to free epsilon amino groups. Therefore, it appears that sulfated glycosaminoglycans, such as heparan sulfate, in the basement membranes of animal tissues can serve as receptors for binding of streptococcal proteins. Streptococcus pyogenes also produces a heparin-inhibitable basement membrane-binding protein with similar physical properties (2) . Although the exact relationship of these bacterial proteins remains to be determined, preliminary experiments have shown that affinity-purified polyclonal antibodies cross-react with purified proteins of both Streptococcus species.
The identities of the tissue structures which bind the 8-kDa protein were revealed by indirect immunofluores- enhanced pathogenicity through their combined effects. Preliminary experiments indicate that the 8-kDa protein is present on the cell wall of S. mutans and can complex with lipoteichoic acid in solution. Additional studies are needed to define the mechanism for its release from the cell and the roles it plays in bacterial adherence to host surfaces and in pathogenesis in vivo.
